{
    "2018-10-11": [
        [
            {
                "time": "",
                "original_text": "智飞生物：四价/九价HPV疫苗、五价轮状疫苗将成为近三年业绩保障",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "四价HPV疫苗",
                        "九价HPV疫苗",
                        "五价轮状疫苗",
                        "业绩保障"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物：预计明年四价HPV疫苗接种紧张状况将得到一定缓解",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "四价HPV疫苗",
                        "接种紧张",
                        "缓解"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【高管面对面直播】智飞生物：“市场+研发”双轮驱动的疫苗民营龙头",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "市场+研发",
                        "双轮驱动",
                        "疫苗",
                        "民营龙头"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}